Cargando…

Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases

Detalles Bibliográficos
Autores principales:	Hashem, Anwar M., Flaman, Anathea S., Farnsworth, Aaron, Brown, Earl G., Van Domselaar, Gary, He, Runtao, Li, Xuguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691368/ http://dx.doi.org/10.1371/annotation/eb17187c-4618-4558-89e4-322d4acc9b04

Ejemplares similares

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014)

Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
por: He, Runtao, et al.
Publicado: (2004)

Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-β
por: Farnsworth, Aaron, et al.
Publicado: (2010)

Erratum to “Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid” [Biochem. Biophys. Res. Commun. 320 (2004) 1199–1203]
por: He, Runtao, et al.
Publicado: (2004)

Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid
por: Park, Jun-Gyu, et al.
Publicado: (2019)

Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines
por: Xu, Kangwei, et al.
Publicado: (2018)

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors
por: Tolah, Ahmed M., et al.
Publicado: (2016)

Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteins
por: Yap, YeeLeng, et al.
Publicado: (2005)

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid
por: Alonso, Celia, et al.
Publicado: (2020)

A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification
por: Hashem, Anwar M., et al.
Publicado: (2013)

Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data
por: Wolkewitz, Martin, et al.
Publicado: (2017)

Correction: Neuraminidase Subtyping of Avian Influenza Viruses with PrimerHunter-Designed Primers and Quadruplicate Primer Pools
por: Huang, Yanyan, et al.
Publicado: (2013)

Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
por: Momont, Corey, et al.
Publicado: (2023)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Aurintricarboxylic acid increases yield of HSV-1 vectors
por: Pechan, Peter, et al.
Publicado: (2014)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Correction: Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis
Publicado: (2014)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011)

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Identification and characterization of aurintricarboxylic acid as a potential inhibitor of SARS-CoV-2 PLpro
por: Arya, Rimanshee, et al.
Publicado: (2023)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells
por: Roos, Alison, et al.
Publicado: (2017)

Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages
por: Gravel, Caroline, et al.
Publicado: (2021)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
por: Lee, Vernon J., et al.
Publicado: (2006)

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
por: Kamali, Amanda, et al.
Publicado: (2013)

Aurintricarboxylic acid is a canonical disruptor of the TAZ-TEAD transcriptional complex
por: Che, Kepeng, et al.
Publicado: (2022)

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
por: Wang, Pengfei, et al.
Publicado: (2021)

Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses†
por: Oakley, Aaron J., et al.
Publicado: (2010)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Correction: Potent and specific MTH1 inhibitors targeting gastric cancer
por: Zhou, Wenjuan, et al.
Publicado: (2020)

Influenza Virus Neuraminidase Structure and Functions
por: McAuley, Julie L., et al.
Publicado: (2019)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

Effects of Vaccination and the New Neuraminidase Inhibitor, Laninamivir, on Influenza Infection
por: Mizuno, Takuro, et al.
Publicado: (2014)

Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada
por: Abed, Yacine, et al.
Publicado: (2019)

Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity
por: Laborda, Pedro, et al.
Publicado: (2016)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
por: Jefferson, Tom, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rst3k6jen426sdululq98243pb